{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:11:57Z","timestamp":1790255517221,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2807,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"crossref","award":["IG11647"],"award-info":[{"award-number":["IG11647"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian Ministry of Health","award":["2009WZHMNJ"],"award-info":[{"award-number":["2009WZHMNJ"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.exphem.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T12:20:38Z","timestamp":1403612438000},"page":"897-908.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation"],"prefix":"10.1016","volume":"42","author":[{"given":"Marco","family":"Tucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Stucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Savonarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Resta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Silvestris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2014.06.005_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple Myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.06.005_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/156802609787521625","article-title":"Role of active drug transporters in refractory multiple myeloma","volume":"9","author":"Tucci","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.exphem.2014.06.005_bib3","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood-2007-05-089193","article-title":"Dysfunctional homologous recombination mediates genomic instability and progression in myeloma","volume":"113","author":"Shammas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.06.005_bib4","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2011-01-327262","article-title":"MEK and MAF in myeloma therapy","volume":"117","author":"Popovic","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.06.005_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2012.05.005","article-title":"Relapsed\/Refractory multiple myeloma: defining refractory disease and identifying strategies to overcome resistance","volume":"49","author":"Siegel","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2014.06.005_bib6","doi-asserted-by":"crossref","first-page":"595976","DOI":"10.1155\/2012\/595976","article-title":"Targeting metabolism and autophagy in the context of haematogical malignancies","volume":"2012","author":"Banerji","year":"2012","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.exphem.2014.06.005_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.2012.079061","article-title":"Autophagy in blood cancers: biological role and therapeutic implications","volume":"98","author":"Nencioni","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.06.005_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ncb1007-1102","article-title":"Autophagosome formation: core machinery and adaptations","volume":"9","author":"Xie","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2014.06.005_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","article-title":"Role of autophagy in cancer","volume":"7","author":"Mathew","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2014.06.005_bib10","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1158\/1535-7163.MCT-08-1177","article-title":"Effect of autophagy on multiple myeloma cell viability","volume":"8","author":"Hoang","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2014.06.005_bib11","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","article-title":"Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML","volume":"118","author":"Helgason","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.06.005_bib12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/auto.5.8.9996","article-title":"Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells","volume":"5","author":"Song","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.exphem.2014.06.005_bib13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiate tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.06.005_bib14","first-page":"251","article-title":"Autophagy in breast cancer and its implications for therapy","volume":"3","author":"Jain","year":"2013","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.exphem.2014.06.005_bib15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4161\/auto.6.7.13038","article-title":"Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis","volume":"6","author":"Hou","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.exphem.2014.06.005_bib16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.05.023","article-title":"p62 at the crossroads of autophagy, apoptosis and cancer","volume":"137","author":"Moscat","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.06.005_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4161\/cbt.22954","article-title":"Prognostic impact of Becli-1, p62\/sequestosome-1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy","volume":"14","author":"Myung Park","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.exphem.2014.06.005_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Ann Rev Genet"},{"key":"10.1016\/j.exphem.2014.06.005_bib19","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition","volume":"67","author":"Meister","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.06.005_bib20","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2009-06-222943","article-title":"PI3K\/p110{delta} is a novel therapeutic target in multiple myeloma","volume":"116","author":"Ikeda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.06.005_bib21","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.2174\/138161212802083653","article-title":"Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer","volume":"18","author":"Mauri\u00f1o","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.exphem.2014.06.005_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nbt.2285","article-title":"Therapeutic targets in cancer cell metabolism and autophagy","volume":"30","author":"Cheong","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2014.06.005_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/0008-5472.CAN-13-2966","article-title":"The four faces of autophagy: implications for cancer therapy","volume":"74","author":"Gewirtz","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.06.005_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4161\/auto.4867","article-title":"Role of autophagy in breast cancer","volume":"3","author":"Karantza-Wadsworth","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.exphem.2014.06.005_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4161\/cbt.11.2.14663","article-title":"Autophagy modulation for cancer therapy","volume":"11","author":"Yang","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.exphem.2014.06.005_bib26","first-page":"220","article-title":"Autophagy is a therapeutic target in anticancer drug resistance","volume":"1806","author":"Chen","year":"2010","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.exphem.2014.06.005_bib27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","article-title":"Autophagy suppresses tumorigenesis through elimination of p62","volume":"137","author":"Mathew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.06.005_bib28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.bjc.6605904","article-title":"Beclin-1 over- and under-expression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia","volume":"103","author":"Koukourakis","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2014.06.005_bib29","article-title":"Inhibition of autophagy promotes bortezomib-mediated cell death in myeloma cells","volume":"112","author":"Landoswki","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.06.005_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10495-006-0624-5","article-title":"Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids","volume":"12","author":"Herr","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.exphem.2014.06.005_bib31","first-page":"1","article-title":"Control of autophagic cell death by caspase-10 in multiple myeloma","volume":"15","author":"Lamy","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.06.005_bib32","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Richardson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.06.005_bib33","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.bbamcr.2008.12.013","article-title":"Role and regulation of autophagy in cancer","volume":"1793","author":"Chen","year":"2009","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.exphem.2014.06.005_bib34","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1158\/1078-0432.CCR-10-0890","article-title":"Targeting autophagy augments in\u00a0vitro and in\u00a0vivo antimyeloma activity of DNA-damaging chemotherapy","volume":"17","author":"Pan","year":"2011","journal-title":"Clin Can Res"},{"key":"10.1016\/j.exphem.2014.06.005_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrclinonc.2011.71","article-title":"Autophagy as a target for anticancer therapy","volume":"8","author":"Janku","year":"2011","journal-title":"Nature Rev Clin Oncol"},{"key":"10.1016\/j.exphem.2014.06.005_bib36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancr: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2014.06.005_bib37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/carcin\/bgt063","article-title":"Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition","volume":"34","author":"Li","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.exphem.2014.06.005_bib38","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V112.11.2755.2755","article-title":"The rationale for combined proteasome and autophagy inhibition in multiple myeloma established using novel translational platforms","volume":"112","author":"Shen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.06.005_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrclinonc.2010.21","article-title":"mTOR signaling and drug development in cancer","volume":"7","author":"Dancey","year":"2010","journal-title":"Nature Rev Clin Oncol"},{"key":"10.1016\/j.exphem.2014.06.005_bib40","doi-asserted-by":"crossref","first-page":"40002","DOI":"10.1074\/jbc.M111.297432","article-title":"Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62\/sequestosome-1","volume":"286","author":"Huang","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.exphem.2014.06.005_bib41","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/leu.2013.150","article-title":"Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K\/mTOR inhibition in myeloma cells is essential for their effective clinical application","volume":"27","author":"Aronson","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.06.005_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/auto.5338","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.exphem.2014.06.005_bib43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2014.06.005_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2014.06.005_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature08455","article-title":"Discovery of Atg5\/Atg7-independent alternative macroautophagy","volume":"461","author":"Nishida","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.06.005_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol Biol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14002392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14002392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:32:01Z","timestamp":1759566721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X14002392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0301472X14002392"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2014.06.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}